Kevin Puylaert
Chief Sales Officer · SOPHiA GENETICS SA
IndividualSelling only
- 2026
- Oct 7, 2026
- 8
Filings (90d)
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Kevin Puylaert files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Jurgi Camblong - $2.65M in SOPH purchases and sales in the last 12 months
- Zhenyu Xu - $761K in SOPH purchases and sales in the last 12 months
- Philippe Menu - $478K in SOPH purchases and sales in the last 12 months
- Abhimanyu Verma - $266K in SOPH purchases and sales in the last 12 months
- Ross Muken - $225K in SOPH purchases and sales in the last 12 months
- Manuela Valente - $159K in SOPH purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Kevin Puylaert?
Kevin Puylaert is a corporate insider, tracked as Chief Sales Officer of SOPHiA GENETICS SA (SOPH). InsiderAlpha holds 8 primary Form 4 filings for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Kevin Puylaert submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Has Kevin Puylaert been buying or selling stock?
Recorded transactions: 0 open-market purchases and 9 open-market sales ($3K) across all tracked filings.
